Boston – June 18, 2018 – Cooley advised Scholar Rock on its $86.3 million initial public offering of 6,164,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Cooley partners Marc Recht, Brent Siler and Nicole Brookshire led the team advising Scholar Rock.

Jefferies, Cowen and BMO Capital Markets acted as joint book-running managers for the offering.  Wedbush PacGrow acted as co-manager.

Scholar Rock is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. It now trades on The Nasdaq Global Select Market as “SRRK.”

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.